(Q77690632)

English

Neutralizing antibodies to interferon beta-1a and interferon beta-1b in MS patients are cross-reactive

scientific article published on 01 December 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

title

Neutralizing antibodies to interferon beta-1a and interferon beta-1b in MS patients are cross-reactive (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

author name string

O A Khan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

S S Dhib-Jalbut

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

publication date

1 December 1998

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

volume

51

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

issue

6

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

page(s)

1698-1702

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

Identifiers

DOI

10.1212/WNL.51.6.1698

1 reference

stated in

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

PubMed ID

9855525

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9855525%20AND%20SRC:MED&resulttype=core&format=json

(Q77690632)

Neutralizing antibodies to interferon beta-1a and interferon beta-1b in MS patients are cross-reactive

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)